Moyamoya disease: General scenario and future perspective
DOI:
https://doi.org/10.33448/rsd-v14i2.48349Keywords:
Moyamoya disease; Quality of life; Mediation analysis; Patient care.Abstract
Moyamoya disease is considered rare and its origin is still unknown, but there is a genetic condition associated with the RNF213 gene related to the disease. However, Asian ethnicity, especially Japanese, is more affected by the disease. The objective of this review was to analyze Moyamoya disease, comorbidities associated with the disease, diagnostic methods, treatments and challenges faced by those with the disease. An integrative review of scientific articles consulted from databases such as the Virtual Health Library (VHL) - BIREME - PAHO - WHO and Medical Publications (PubMed) - via the National Library of Medicine (NLM) and some websites related to the disease in the last 23 years was used as methodology. After consulting the databases, 18 articles were selected, 6 about the disease, associated comorbidities and diagnosis, 6 about treatments, 3 about factors that influence treatment and 3 about life expectancy and quality of life, many of which are case reports. Referring to a rare and serious disease, there is a need for further studies related to MMD, since this disease is often associated with other rare and serious comorbidities, and requires surgical and multidisciplinary treatment for the patient to have a better quality of life and life expectancy. There is much to be explored regarding MMD to improve quality of life, considering that it is an incurable disease to this day with very limited treatment alternatives.
References
Adamo Junior, J., Paradela, M. V. D. H., & Horigushi, M. (2001). Doença cerebrovascular oclusiva crônica (Moyamoya): relato de caso. Arquivos de Neuro-Psiquiatria, 59(2B), 435–439. https://doi.org/10.1590/s0004-282x2001000300024
Amlie-Lefond, C., Zaidat, O. O., & Lew, S. M. (2011). Moyamoya disease in early infancy: Case report and literature review. Pediatric Neurology, 44(4), 299–302. https://doi.org/10.1016/j.pediatrneurol.2010.10.016
Baba, T., Houkin, K., & Kuroda, S. (2008). Novel epidemiological features of Moyamoya disease. Journal of Neurology, Neurosurgery & Psychiatry, 79(8), 900–904. https://doi.org/10.1136/jnnp.2007.130666
Ball, A. J., Steinberg, G. K., & Elbers, J. (2016). Quality of life in pediatric Moyamoya disease. Pediatric Neurology, 63, 60–65. https://doi.org/10.1016/j.pediatrneurol.2016.06.012
Boehme, A. K., Esenwa, C., & Elkind, M. S. V. (2017). Stroke risk factors, genetics, and prevention. Circulation Research, 120(3), 472–495. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321635/
Chen, X., Lei, Y., Su, J., Yang, H., Ni, W., Yu, J., Gu, Y., & Mao, Y. (2022). A review of artificial intelligence in cerebrovascular disease imaging: Applications and challenges. Current Neuropharmacology, 20(7), 1359–1382. https://doi.org/10.2174/1570159x19666211108141446
Crossetti, M. G. M. (2012). Revisión integradora de la investigación en enfermería el rigor científico que se le exige. Rev. Gaúcha Enferm. 33 (2): 8-9
Demartini Jr., Z., Teixeira, B. CA., Koppe, G. L., Gatto, L. A. M., Roman, A., & Munhoz, R. P. (2022). Moyamoya disease and syndrome: a review. Radiologia Brasileira, 55(1), 31–37. https://doi.org/10.1590/0100-3984.2021.0010
Fujimura, M., Oh Young Bang, & Jong Min Kim. (2016). Moyamoya disease. S. Karger AG EBooks, 204–220. https://doi.org/10.1159/000448314
Fukui, M., Kono, S., Sueishi, K., & Ikezaki, K. (2000). Moyamoya disease. Neuropathology, 20(s1), 61–64. https://doi.org/10.1046/j.1440-1789.2000.00300.x
Guey, S., Tournier-Lasserve, E., Hervé, D., & Kossorotoff, M. (2015). Moyamoya disease and syndromes: from genetics to clinical management. The Application of Clinical Genetics, 8, 49–68. https://doi.org/10.2147/TACG.S42772
Hishikawa, T., Sugiu, K., & Date, I. (2016). Moyamoya disease: A review of clinical research. Acta Medica Okayama, 70(4), 229–236. https://doi.org/10.18926/AMO/54497
Ibrahimi, D. M., Tamargo, R. J., & Ahn, E. S. (2010). Moyamoya disease in children. Child’s Nervous System, 26(10), 1297–1308. https://doi.org/10.1007/s00381-010-1209-8
Kelly, M., Bell-Stephens, T., Marks, M. P., Huy M, & Steinberg, G. K. (2006). Progression of unilateral Moyamoya disease: A clinical series. Cerebrovascular Diseases, 22(2-3), 109–115. https://doi.org/10.1159/000093238
Kim, J. S. (2016). Moyamoya disease: epidemiology, clinical features, and diagnosis. Journal of Stroke, 18(1), 2–11. https://doi.org/10.5853/jos.2015.01627
Kuroda, S., Ishikawa, T., Houkin, K., Nanba, R., Hokari, M., & Iwasaki, Y. (2005). Incidence and clinical features of disease progression in adult Moyamoya disease. Stroke, 36(10), 2148–2153. https://doi.org/10.1161/01.str.0000182256.32489.99
Lamônica, D. A. C., Ribeiro, C. da C., Ferraz, P. M. D. P., & Tabaquim, M. de L. M. (2016). Doença de Moyamoya: impacto no desempenho da linguagem oral e escrita. CoDAS, 28(5), 661–665. https://doi.org/10.1590/2317-1782/20162016010
Lavratti, V. B., Soares, A. C. de A., Bandeira, J. L. C., Fontana-Júnior, F., Pandolfo, I. Á (2021). Doença de Moyamoya: revisão bibliográfica e relato de 1 caso. Revista Thêma Et Scientia, 1(11), 115-129.
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., & McGuinness, L. A. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. British Medical Journal, 372(71). https://doi.org/10.1136/bmj.n71
Peerless, S. J. (1997). Risk factors of Moyamoya disease in Canada and the USA. Clinical Neurology and Neurosurgery, 99, S45–S48. https://doi.org/10.1016/s0303-8467(97)00039-5
Pereira A. S. et al. (2018). Metodologia da pesquisa científica. [free e-book]. Santa Maria/RS. Ed. UAB/NTE/UFSM.
Scott, R. M., & Smith, E. R. (2009). Moyamoya disease and Moyamoya syndrome. New England Journal of Medicine, 360(12), 1226–1237. https://doi.org/10.1056/nejmra0804622
Smith, E. R., & Scott, R. M. (2008). Progression of disease in unilateral Moyamoya syndrome. Neurosurgical Focus, 24(2), E17. https://doi.org/10.3171/foc/2008/24/2/e17
Silva, C. O. G. da, & Ribeiro, R. S. (2020). Doença de Moyamoya: um relato de caso / Moyamoya disease: a case report. Brazilian Journal of Health Review, 3(6), 16431–16439. https://doi.org/10.34119/bjhrv3n6-065
Silva, D. B. da Hagemann, P. de M. S., Pereira, C., & Neme, C. M. B. (2017). Experiências e sentimentos de mães diante da doença de Moyamoya de seus filhos. Estudos de Psicologia (Campinas), 34(4), 523–533. https://doi.org/10.1590/1982-02752017000400008
Shang, S., Zhou, D., Ya, J., Li, S., Yang, Q., Ding, Y., Ji, X., & Meng, R. (2018). Progress in Moyamoya disease. Neurosurgical Review, 43(2), 371–382. https://doi.org/10.1007/s10143-018-0994-5
Snyder, H. (2019). Literature review as a research methodology: An overview and guidelines. Journal of business research, 104, 333-339.
Suwanwela, N.C. (2023). UpToDate. Moyamoya disease and Moyamoya syndrome: treatment and prognosis. https://www.uptodate.com/contents/moyamoya-disease-and-moyamoya-syndrome-treatment-and-prognosis?search=22.
Rupareliya C., Lui F. (2023). National Center for Biotechnology Information. Moyamoya Disease - StatPearls - NCBI Bookshelf. http://www.ncbi.nlm.nih.gov/books/NBK535455
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Yasmi Dias Teran Maigua; Maria Aparecida Nicoletti
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
